FindTrial
Sign In

Study of mutations in mtDNA (mitochondraial DNA) in urothelial (Bladder) cancer of bladder

Study of mtDNA mutations in urothelial carcinoma of bladder

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/02/023139
Enrollment
40
Registered
2020-02-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C679- Malignant neoplasm of bladder, unspecified

Interventions

None listed

Sponsors

KEM Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: In summary: All Carcinoma bladder patients undergoing Transurethral resection / Radical cystectomy at Dept. of Urology, KEMH

Exclusion criteria

Exclusion criteria: All patient undergoing TURBT whose biopsy report turns out to be non malignant. Patients who donâ??t give consent.

Design outcomes

Primary

MeasureTime frame
To identify the mutations in mt DNA gene in bladder cancer cases and comparing it with the normal tissue geneticsTimepoint: 1 year—

Secondary

MeasureTime frame
To correlate the results of these mutations with clinical and pathological variables vis a vis grade, stage at presentationTimepoint: 1 year—

Countries

India

Contacts

Public ContactSujata Patwardhan

Seth G. S. Medical College and KEM Hospital

Kemurology123@gmail.com9653477079

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026